CD Formulation is a biopharmaceutical company focusing on therapeutic proteins and peptides, dedicated to developing and producing biotherapeutics using advanced technology and innovative methods. Importantly, we excel at converting these therapeutic proteins/peptides into oral drugs as well as other formulations utilizing innovative drug delivery technologies, thus enhancing the bioavailability and efficacy of the drugs, improving the patient treatment experience, and driving the development of the biopharmaceutical industry. We believe in continuous innovation and research...
Innovative drug delivery carriers solve your therapeutic proteins and peptides stability issues.
CD Formulation deeply understands the importance of therapeutic proteins and peptides in the pharmaceutical industry, focusing on providing the biopharmaceutical industry with one-stop solutions for protein and peptide development and manufacturing, from cell line culture, upstream and downstream process development, and formulation development to cGMP manufacturing.
CD Formulation has extensive experience and expertise in the synthesis and production of a wide range of therapeutic proteins and peptides, including novel continuous flow methods, conventional solid phase peptides, recombinant DNA methods, fermentation, etc.
CD Formulation supports one-stop development services from upstream to downstream bioprocessing, including cell line development and cell culture, upstream process development, downstream process development...
CD Formulation provides high-quality formulation development services for various therapeutic proteins and peptides, including monoclonal antibodies, bispecific antibodies, nanobodies, fusion proteins, therapeutic peptides, etc.
CD Formulation provides a full range of analytical tests to characterize therapeutic proteins and peptides and their formulations, including structure, particle and aggregation state, viscosity, stability and thermal denaturation...
CD Formulation provides fully integrated quality control and release testing for proteins and peptides, from analytical method development, validation, and transfer to batch release testing, ensuring the highest quality of your products.
CD Formulation has a series of facilities that comply with current good manufacturing practice (cGMP) requirements and is committed to providing you with total solutions for therapeutic protein & peptide CGMP manufacturing...
CD Formulation is an expert in formulation science and pharmaceutical process development in therapeutic proteins and peptides. Let's work together to move your program forward.
Therapeutic proteins and peptides offer promising avenues for developing new treatments for a variety of diseases and conditions. These molecules can target specific pathways in the body to regulate or correct dysfunctional processes, making them valuable tools in the treatment of a variety of diseases. One of their major advantages is their ability to specifically target and modulate the activity of specific proteins or pathways in the body. This targeted approach could lead to more effective and less toxic treatments than traditional small-molecule drugs that may produce off-target effects.